CAPTRUST Financial Advisors’s Celldex Therapeutics CLDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-618
| Closed | -$17K | – | 2417 |
|
2022
Q2 | $17K | Buy |
618
+574
| +1,305% | +$15.8K | ﹤0.01% | 3450 |
|
2022
Q1 | $1K | Sell |
44
-72
| -62% | -$1.64K | ﹤0.01% | 4666 |
|
2021
Q4 | $4K | Sell |
116
-1,506
| -93% | -$51.9K | ﹤0.01% | 4166 |
|
2021
Q3 | $88K | Buy |
+1,622
| New | +$88K | ﹤0.01% | 2172 |
|